Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy.
The use of chemopreventive natural compounds represents a promising strategy in the search for novel therapeutic agents in cancer. Resveratrol (3,4',5-trans-trihydroxystilbilene) is a dietary polyphenol found in fruits, vegetables and medicinal plants that exhibits chemopreventive and antitumor...
Main Authors: | José Díaz-Chávez, Miguel A Fonseca-Sánchez, Elena Arechaga-Ocampo, Ali Flores-Pérez, Yadira Palacios-Rodríguez, Guadalupe Domínguez-Gómez, Laurence A Marchat, Lizeth Fuentes-Mera, Guillermo Mendoza-Hernández, Patricio Gariglio, César López-Camarillo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3664632?pdf=render |
Similar Items
-
Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27.
by: Yohann Bernard, et al.
Published: (2011-01-01) -
DNA methylation data for identification of epigenetic targets of resveratrol in triple negative breast cancer cells
by: Rubiceli Medina-Aguilar, et al.
Published: (2017-04-01) -
Hsp27-Actin Interaction
by: Philip Graceffa
Published: (2011-01-01) -
The Drosophila hsp27 promoter
by: Riddihough, Guy
Published: (1988) -
Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol.
by: Rubiceli Medina-Aguilar, et al.
Published: (2016-01-01)